Elevance Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Elevance Health generated cash of $8,061,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$3,349,000,000 last year. Net change in cash is therefore -$861,000,000.
Cash Flow
| 2014 | 3.36B | -974.9M | -1.82B |
|---|---|---|---|
| 2015 | 4.11B | -1.15B | -2.99B |
| 2016 | 3.20B | -513.9M | -732.9M |
| 2017 | 4.18B | -5.08B | 426.9M |
| 2018 | 3.82B | -1.25B | -2.24B |
| 2019 | 6.06B | -2.79B | -2.26B |
| 2020 | 10.68B | -7.32B | -2.56B |
| 2021 | 8.36B | -9.63B | 423M |
| 2022 | 8.39B | -4.56B | -1.31B |
| 2023 | 8.06B | -5.57B | -3.34B |
ELV Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.38B | 4.88B | 5.74B | 4.93B | 3.93B | 3.60B | 4.07B | 2.11B | 2.15B | 1.58B |
Operating activities | ||||||||||
Net income | 5.99B | 6.01B | 6.09B | 4.57B | 4.80B | 3.75B | 3.84B | 2.46B | 2.56B | 2.56B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.74B | 1.67B | 1.30B | 1.15B | 1.13B | 1.12B | 890.4M | 911.8M | 907.9M | 851M |
Stock-based compensation expense | 289M | 264M | 255M | 283M | 294M | 226M | 169.6M | 164.6M | 148.2M | 168.9M |
| Deferred income tax benefit | 289M | 264M | 255M | 283M | 294M | 226M | 169.6M | 164.6M | 148.2M | 168.9M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -2.51B | -2.13B | -256M | -1.05B | -707M | -22.2M | -1.38B | -42.9M | -1.89B |
Inventories | 0 | 2.51B | 2.13B | 256M | 593M | -1.09B | -53.1M | 780.3M | 919.1M | 1.61B |
Accounts payable | 1.64B | 252M | 719M | 1.97B | -593M | 122M | 921.8M | 116.6M | -219.3M | -14.4M |
Cash generated by operating activities | 8.06B | 8.39B | 8.36B | 10.68B | 6.06B | 3.82B | 4.18B | 3.20B | 4.11B | 3.36B |
Investing activities | ||||||||||
Purchases Of Investments | -16.23B | -24.94B | -18.66B | -19.49B | -22.95B | -9.67B | -16.37B | -12.10B | -11.89B | -10.79B |
Investments In Property Plant And Equipment | -1.29B | -1.15B | -1.08B | -1.02B | -1.07B | -1.20B | -790.2M | -583.6M | -602.9M | -626.6M |
Acquisitions Net | -1.55B | -649M | -3.47B | -1.97B | 0 | -1.76B | -2.07B | 0 | -638.9M | 740M |
Cash generated by investing activities | -5.57B | -4.56B | -9.63B | -7.32B | -2.79B | -1.25B | -5.08B | -513.9M | -1.15B | -974.9M |
Financing activities | ||||||||||
Common Stock Issued | 152M | 0 | 5.99B | 1.57B | 0 | 1.25B | 0 | 119.4M | 0 | 301.3M |
Payments for dividends | -1.39B | -1.22B | -1.10B | -954M | -818M | -776M | -704.9M | -684M | -656.6M | -480.7M |
Repurchases of common stock | -2.67B | -2.31B | -1.9B | -2.7B | -1.70B | -1.68B | -1.99B | 191.8M | -1.51B | -2.99B |
Repayments of term debt | 665M | 1.17B | -2.11B | -850M | 608M | -1.29B | 3.72B | -53.2M | -892.3M | -379.2M |
Cash used in financing activities | -3.34B | -1.31B | 423M | -2.56B | -2.26B | -2.24B | 426.9M | -732.9M | -2.99B | -1.82B |
Net Change In Cash | -861M | 2.50B | -861M | 804M | 1.00B | 325M | -466.4M | 1.96B | -38.2M | 564.8M |
Cash at end of period | 6.52B | 7.38B | 4.88B | 5.74B | 4.93B | 3.93B | 3.60B | 4.07B | 2.11B | 2.15B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |